salmeterol xinafoate has been researched along with L-isoprenaline in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barrett, VJ; Biggadike, K; Butchers, PR; Craven, A; Ford, AJ; Guntrip, SB; Holmes, DS; Hughes, SC; Jones, AE; Looker, BE; Mutch, PJ; Needham, D; Procopiou, PA; Ruston, M; Smith, CE | 1 |
| Bouvier, M; Gmeiner, P; Hübner, H; Kaindl, JM; Picard, LP; Schmidt, MF; Stanek, M; Weikert, D | 1 |
2 other study(ies) available for salmeterol xinafoate and L-isoprenaline
| Article | Year |
|---|---|
Discovery of a rapidly metabolized, long-acting β(2) adrenergic receptor agonist with a short onset time incorporating a sulfone group suitable for once-daily dosing.
Topics: Adrenergic beta-2 Receptor Agonists; Animals; CHO Cells; Cricetinae; Cricetulus; Dogs; Drug Administration Schedule; Drug Discovery; Guinea Pigs; Hepatocytes; Humans; Rats; Sulfones; Trachea | 2014 |
Hybridization of β-Adrenergic Agonists and Antagonists Confers G Protein Bias.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; beta-Arrestins; Carvedilol; Catechols; Drug Design; GTP-Binding Proteins; Humans; Hydrogen Bonding; Indicators and Reagents; Isoproterenol; Ligands; Mice; Models, Molecular; Molecular Dynamics Simulation; Salmeterol Xinafoate | 2019 |